The purpose of this study was to screen genes that may affect the efficacy of HER2-positive breast cancer drugs, explore their functional phenotypes in the drug sensitivity of HER2-positive breast cancer, and investigate the possible mechanisms underlying drug sensitivity. Here, ERBB2 is linked to breast cancer.